A new edition of the EPO Examination Guidelines came into force on 1 March 2021, including a new section on the examination of claims to antibodies. This is very welcome and, appropriately for examination guidelines, it does not contain any major surprises compared to our typical experiences of handling antibody patent applications at the EPO. Chris Denison gives an overview of antibody patenting practice at the EPO and comments on the new guidelines in the recording of his seminar below. You can download the slides here.